Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects

Hypertension

Volumn 42, Issue 3, 2003, Pages 283-290

  Hermida, Ramón C ^a   Calvo, Carlos ^b   Ayala, Diana E ^a   Domínguez, María J ^b   Covelo, Manuel ^b   Fernández, José R ^a   Mojón, Artemio ^a   López, José E ^b  

^a UNIVERSITY OF VIGO   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Antihypertensive agents; Blood pressure monitoring, ambulatory; Circadian rhythm; Receptors, angiotensin

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; VALSARTAN;

ACTIMETRY; ADULT; AMBULATORY MONITORING; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CHRONOTHERAPY; CIRCADIAN RHYTHM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE;

ADULT; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL MARKERS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CIRCADIAN RHYTHM; DIASTOLE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SYSTOLE; TETRAZOLES; TREATMENT OUTCOME; VALINE;

EID: 0041331792     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000084855.32823.DA     Document Type: Article

References (32)

1. Guidelines Subcommittee. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999;17:151-183.
2. Markham A, Goa KL. Valsartan: a review of its pharmacology and therapeutic use in essential hypertension. Drugs. 1997;54:299-311.
3. Neutel J, Weber M, Pool J, Smith D, Fitzsimmons S, Chiang YT, Gatlin M. Valsartan, a new angiotensin II antagonist: antihypertensive effects over 24 hours. Clin Ther. 1997;19:447-458.
4. Lasko BH, Laplante A, Hebert D, Bonnefis-Boyer S. Canadian valsartan study in patients with mild-to-moderate hypertension. Blood Press Monit. 2001;6:91-99.
5. Elliot HL. Trough:peak ratio and twenty-four-hour blood pressure control. J Hypertens. 1994;12(suppl 5):S29-S33.
6. Lemmer B. Cardiovascular chronobiology and chronopharmacology. In: Touitou Y, Haus E, eds. Biologic Rhythms in Clinical and Laboratory Medicine. Berlin, Germany: Springer-Verlag; 1992:418-427.
7. Portaluppi F, Smolensky MH. Circadian rhythm and environmental determinants of blood pressure regulation in normal and hypertensive conditions. In: White WB, ed. Blood Pressure Monitoring in Cardiovascular Medicine and Therapeutics. Totowa, NJ: Humana Press; 2000:79-118.
8. Hermida RC, Ayala DE, Fernández JR, Mojón A, Alonso I, Calvo C. Modeling the circadian variability of ambulatorily monitored blood pressure by multiple-component analysis. Chronobiol Int. 2002;19:461-481.
9. Palatini P, Mos L, Motolese M, Mormino P, Del Torre M, Varotto L, Pavan E, Pessina AC. Effect of evening versus morning benazepril on 24-hour blood pressure: a comparative study with continuous intraarterial monitoring. Int J Clin Pharmacol Ther Toxicol. 1993;31:295-300.
10. Witte K, Weisser K, Neubeck M, Mutschler E, Lehmann K, Hopf R, Lemmer B. Cardiovascular effects, pharmacokinetics and converting enzyme inhibition of enalapril after morning versus evening administration. Clin Pharmacol Ther. 1993;54:177-186.
11. Palatini P, Racioppa A, Raule G, Zaninotto M, Penzo M, Pessina AC. Effect of timing of administration on the plasma ACE inhibitory activity and the antihypertensive effect of quinapril. Clin Pharmacol Ther. 1992;52:378-383.
12. Myburgh DP, Verho M, Botes JH, Erasmus ThP, Luus HG. 24-Hour pressure control with ramipril: comparison of once-daily morning and evening administration. Curr Ther Res. 1995;56:1298-1306.
13. Morgan T, Anderson A, Jones E. The effect on 24 h blood pressure control of an angiotensin converting enzyme inhibitor (perindopril) administered in the morning or at night. J Hypertens. 1997;15:205-211.
14. Svensson P, de Faire U, Sleight P, Yusuf S, Östergren J. Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE substudy. Hypertension. 2001;38:e28-e32.
15. O'Brien E, Sheridan J, O'Malley K. Dippers and non-dippers. Lancet. 1988;13:397. Letter.
16. Portaluppi F, Vergnani L, Manfredini R, degli Uberti EC, Fersini C. Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens. 1995;8:719-726.
17. Nold G, Strobel G, Lemmer B. Morning vs evening amlodipine treatment: effect on circadian blood pressure profile in essential hypertensive patients. Blood Press Monit. 1998;3:17-25.
18. Lemmer B, Nold G, Behne S, Kaiser R. Chronopharmacokinetics and cardiovascular effects of nifedipine. Chronobiol Int. 1991;8:485-494.
19. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997;157:2413-2446.
20. O'Brien E, Staessen J. Normotension and hypertension as defined by 24-hour ambulatory blood pressure monitoring. Blood Press. 1995;4:266-282.
21. Mansoor GA, White WB, McCabe EJ, Giacco S. The relationship of electronically monitored physical activity to blood pressure, heart rate, and the circadian blood pressure profile. Am J Hypertens. 2000;13:262-267.
22. Hermida RC, Calvo C, Ayala DE, Mojón A, López JE. Relationship between physical activity and blood pressure in dipper and nondipper hypertensive patients. J Hypertens. 2002;20:1097-1104.
23. Staessen J, Fagard R, Lijnen P, Thijs L, van Hoof R, Amery A. Ambulatory blood pressure monitoring in clinical trials. J Hypertens. 1991;9(suppl 1):s13-s19.
24. Fernández JR, Hermida RC. Inferential statistical method for analysis of nonsinusoidal hybrid time series with unequidistant observations. Chronobiol Int. 1998;15:191-204.
25. Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65-70.
26. Parati G, Omboni S, Rizzoni D, Agabiti-Rosei E, Mancia G. The smoothness index: a new, reproducible and clinically relevant measure of the homogeneity of the blood pressure reduction with treatment for hypertension. J Hypertens. 1998;16:1685-1691.
27. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistell M, Guerrieri M, Gatteschi C, Zampi I, Santucci A, Santucci C, Reboldi G. Ambulatory blood pressure: an independent predictor of prognosis in essential hypertension. Hypertension. 1994;24:793-801.
28. Staessen JA, Thijs L, Fagard R, O'Brien ET, Clement D, de Leeuw PW, Mancia G, Nachev C, Palatini P, Parati G, Tuomilehto J, Webster J, for the Systolic Hypertension in Europe (Syst-Eur) trial investigators. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. JAMA. 1999;282:539-546.
29. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, Matsubara M, Hashimoto J, Hoshi H, Araki T, Tsuji I, Satoh H, Hisamichi S, Imai Y. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens. 2002;20:2183-2189.
30. Pickering TG. The clinical significance of diurnal blood pressure variations: dippers and nondippers. Circulation. 1990;81:700-702.
31. Mochizuki Y, Okutani M, Donfeng Y, Iwasaki H, Takusagawa M, Kohno I, Mochizuki S, Umetani K, Ishii H, Ijiri H, Komori S, Tamura K. Limited reproducibility of circadian variation in blood pressure dippers and nondippers. Am J Hypertens. 1998;11:403-409.
32. Hermida RC, Calvo C, Ayala DE, Fernández JR, Ruilope LM, López JE. Evaluation of the extent and duration of the 'ABPM effect' in hypertensive patients. J Am Coll Cardiol. 2002;40:710-717.